IR@PKUHSC  > 北京大学临床研究所
学科主题临床医学
Comparative study of the efficacy and safety between blonanserin and risperidone for the treatment of schizophrenia in Chinese patients: A double-blind, parallel-group multicenter randomized trial
Li, Huafang1; Yao, Chen2; Shi, Jianguo3; Yang, Fude4; Qi, Shuguang5; Wang, Lili6; Zhang, Honggeng7; Li, Jie8; Wang, Chuanyue9; Wang, Chuansheng10; Liu, Cui11; Li, Lehua12; Wang, Qiang13; Li, Keqing14; Luo, Xiaoyan15; Gu, Niufan1
关键词Antipsychotic Agents Blonanserin Randomized Controlled Trial Risperidone Schizophrenia
刊名JOURNAL OF PSYCHIATRIC RESEARCH
2015-10-01
DOI10.1016/j.jpsychires.2015.07.015
69页:102-109
收录类别SCI ; SSCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Psychiatry
研究领域[WOS]Psychiatry
英文摘要

This randomized, double-blind study compared the efficacy and safety of blonanserin and risperidone to treat Chinese schizophrenia patients aged >= 18 and < 65 years. Patients with Positive and Negative Syndrome Scale (PANSS) total scores >= 70 and <= 120 were randomized to receive blonanserin or risperidone using a gradual dose-titration method (blonanserin tablets: 8-24 mg/day; risperidone tablets: 2-6 mg/day), twice daily. Treatment populations consisted of 128 blonanserin-treated patients and 133 risperidone-treated patients. Intention-to-treat analysis was performed using the last observation carried forward method. Reductions of PANSS total scores by blonanserin and risperidone treatment were -30.59 and -33.56, respectively. Risperidone treatment was associated with elevated levels of serum prolactin (67.16% risperidone versus 5231% blonanserin) and cardiac-related abnormalities (2239% risperidone versus 12.31% blonanserin), and blonanserin patients were more prone to extrapyramidal side effects (48.46% blonanserin versus 29.10% risperidone). In conclusion, blonanserin was as effective as risperidone for the treatment of Chinese patients with schizophrenia. The overall safety profiles of these drugs are comparable, although blonanserin was associated with a higher incidence of EPS and risperidone was associated with a higher incidence of prolactin elevation and weight gain. Thus, blonanserin is useful for the treatment of Chinese schizophrenia patients. (C) 2015 The Authors. Published by Elsevier Ltd.

语种英语
WOS记录号WOS:000361927800016
资助机构Sumitomo Pharmaceutical (Suzhou) Co., Ltd.
引用统计
被引频次:5[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/53793
专题北京大学临床研究所
作者单位1.Tianjin Anding Hosp, Dept Psychiat, Tianjin 300222, Peoples R China
2.Henan Prov Mental Hosp, Dept Psychiat, Xinxiang 453002, Peoples R China
3.Hebei Mental Hlth Ctr, Dept Psychiat, Baoding 071000, Peoples R China
4.Sumitomo Pharma Suzhou Co Ltd, Div Med, Beijing 100007, Peoples R China
5.Wuxi Mental Hlth Ctr, Dept Psychiat, Wuxi 214000, Peoples R China
6.Peking Univ, Clin Res Inst, Beijing 100191, Peoples R China
7.Xian Mental Hlth Ctr, Dept Psychiat, Xian 710061, Peoples R China
8.Beijing Huilongguan Hosp, Dept Psychiat, Beijing 100096, Peoples R China
9.Shanghai Mental Hlth Ctr, Dept Psychiat, Shanghai 200030, Peoples R China
10.Brains Hosp Hunan Prov, Dept Psychiat, Changsha 410007, Hunan, Peoples R China
11.Guangzhou Brain Hosp, Dept Psychiat, Guangzhou 510370, Guangdong, Peoples R China
12.Capital Med Univ, Beijing Anding Hosp, Dept Psychiat, Beijing 100088, Peoples R China
13.Peking Univ, Hosp 6, Dept Psychiat, Beijing 100191, Peoples R China
14.Cent S Univ, Xiangya Hosp 2, Dept Psychiat, Changsha 410000, Hunan, Peoples R China
15.Sichuan Univ, West China Hosp, Dept Psychiat, Chengdu 610041, Peoples R China
推荐引用方式
GB/T 7714
Li, Huafang,Yao, Chen,Shi, Jianguo,et al. Comparative study of the efficacy and safety between blonanserin and risperidone for the treatment of schizophrenia in Chinese patients: A double-blind, parallel-group multicenter randomized trial[J]. JOURNAL OF PSYCHIATRIC RESEARCH,2015,69:102-109.
APA Li, Huafang.,Yao, Chen.,Shi, Jianguo.,Yang, Fude.,Qi, Shuguang.,...&Gu, Niufan.(2015).Comparative study of the efficacy and safety between blonanserin and risperidone for the treatment of schizophrenia in Chinese patients: A double-blind, parallel-group multicenter randomized trial.JOURNAL OF PSYCHIATRIC RESEARCH,69,102-109.
MLA Li, Huafang,et al."Comparative study of the efficacy and safety between blonanserin and risperidone for the treatment of schizophrenia in Chinese patients: A double-blind, parallel-group multicenter randomized trial".JOURNAL OF PSYCHIATRIC RESEARCH 69(2015):102-109.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Li, Huafang]的文章
[Yao, Chen]的文章
[Shi, Jianguo]的文章
百度学术
百度学术中相似的文章
[Li, Huafang]的文章
[Yao, Chen]的文章
[Shi, Jianguo]的文章
必应学术
必应学术中相似的文章
[Li, Huafang]的文章
[Yao, Chen]的文章
[Shi, Jianguo]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。